clinical trials

Three of Chicago’s leading medical centers join national network for emergency medicine clinical trials

October 4, 2017

A new national network will collaborate to conduct clinical trials to improve the outcomes for patients with neurologic, cardiac, respiratory, hematologic and trauma-related emergency events. [Read more]

From molecule to medicine: pursuing insight and new treatment for Alzheimer’s disease

September 19, 2017

From bench to bedside, UChicago researchers discuss their role and the existing challenges in finding new medications for Alzheimer’s disease. [Read more]

The immunotherapy revolution

May 3, 2017

Immunotherapy has revolutionized cancer treatment--but not for everyone. See how UChicago researchers are overcoming these barriers to help more patients. [Read more]

Study adds diabetes drug to current state-of-the-art therapy for patients with ovarian cancer

May 20, 2015

The University of Chicago Medicine is leading a clinical trial that will add metformin, a drug commonly used for type II diabetes, to the most effective current therapy for patients with stage 3 or stage 4 ovarian cancer. [Read more]

Puppy Love: Meet Milo, a Portuguese Water Dog with a nose for research

April 13, 2015

Meet Milo, a shaggy, 2-year-old service dog who is helping University of Chicago researchers study how pets can reduce stress levels in patients. [Read more]

Designing a better clinical trial to sort out complex tumors

February 24, 2015

Oncologist Daniel Catenacci designed a "supercontinent" of clinical trials to find the best treatments for patients with esophageal and gastric cancers. [Read more]

UCM trial of early physical and occupational therapy named one of top-15 physiotherapy trials ever

October 29, 2014

A UChicago clinical trial of early physical and occupational therapy in critically ill patients has been selected as one of the 15 most significant physiotherapy trials ever published. [Read more]

UChicago Medicine and Advocate receive NIH grant to establish Type 1 Diabetes TrialNet center

August 12, 2014

The $1.2 million grant will establish the first Type 1 Diabetes TrialNet Clinical Center in Chicago, to identify people at risk or in the early stages of type 1 diabetes and offer them the chance to participate in clinical studies. [Read more]

Dimon in the Rough

July 7, 2014

The optimism for recovery surrounding J.P. Morgan CEO Jamie Dimon's public diagnosis of throat cancer highlights the advances made in treating head and neck cancers. [Read more]

University Of Chicago Chosen As A Center For New Cancer Clinical Trials Network

May 14, 2014

A team from the University of Chicago Medicine Comprehensive Cancer Center will serve as a Lead Academic Participating Site for the newly created National Clinical Trials Network (NCTN). [Read more]